Benchling · San Francisco, CA, USA

Benchling

$6.1B+27% revenueGrowth

Fundamentalsi

Latest valuation$6.1B
Credibility rating5/5
Revenue / run rateNot disclosed
Known investorsY Combinator
StageGrowth
Latest roundSeries F · $100M
Total funding$412M
Team size750 employees
LocationSan Francisco, CA, USA
IndustryB2B
Source records2

Ownership data

Cap table not disclosed

Benchling does not include shareholding history in the normalized startup source files.

Financial performance

All Financials
Source snapshot
REVENUE (USD)Not disclosed +27%
FUNDING (USD)$412M Series F · $100M
Insufficient history

Historical revenue and profit series are not present in the source files for this private company.

REVENUE GROWTHVALUE

1Y (TTM)+27%

3Y CAGR+80% CAGR

PROFIT GROWTHVALUE

1Y (TTM)+80%

3Y CAGR+80% CAGR

About

Biotechnology is rewriting life as we know it, from the medicines we take, to the crops we grow, the materials we wear, and the household goods that we rely on every day. Biotech R&D is radically transforming our world, but to move at the new speed of science, scientists need better technology. Benchling's mission is to unlock the power of biotechnology. The world's biotech leaders and innovators use our R&D Cloud to power the development of breakthrough products and accelerate time to milestone and market.

This profile is normalized from the startup source files. Exact historical financials are shown only when present in the dataset.

CEO/MDGetLatka. How BenchlingFounded in2012StatusStartup profile

Sources

Angel Investors and Venture Capital (1)

InvestorTypeSignal
Y CombinatorAccelerator / VCSeries F · $100M

Similar companies

See more